Achilles Therapeutics jumps on U.S., European patents for cancer detection method

Achilles Therapeutics

25/08/2021 16:55

** U.S.-listed shares of biopharma co  ACHL.O  rise as much
as 6.7% to $6.67 
    ** ACHL was granted patents in the U.S. and Europe for co's
method of detecting cancer 
    ** Co's cancer detection method shows the total number of a
type of mutated proteins, called clonal neoantigens, for a
patient
    ** Patents based on early-stage data showing that patients
with a higher number of clonal neoantigens respond better to
checkpoint inhibitor, a type of immunotherapy treatment for
cancer 
    ** Over 109,000 shares change hands vs 25-day average volume
of ~227,000 during morning trade 
    ** Up to Tuesday's close, ACHL down ~65% since Nasdaq debut
in March 

 (Reporting by Bhanvi Satija)
 ((Bhanvi.Satija@thomsonreuters.com;))